November 22, 2024
Endo USA, Inc, has expanded its previously announced recall of clonazepam orally disintegrating tablets due to a packaging error that could be life-threatening. An ongoing investigation […]
November 21, 2024
Amid substantially rising opioid-related deaths and other harms in Canada, the city of Calgary is grappling with the potential closure of the Sheldon Chumir supervised consumption […]
November 21, 2024
LISBON, PORTUGAL — Almost half of surveyed LGBTQ+ people born in Sweden have experienced perceived discrimination and more than a third have mental health symptoms, according […]
November 20, 2024
Two US Food and Drug Administration (FDA) advisory panels are urging the agency to eliminate the risk management program for the antipsychotic drug clozapine, saying that […]
November 20, 2024
Suicide and self-harm continue to be serious concerns in Europe, despite decreasing rates over the past two decades. In 2021 alone, 47,346 people died by suicide […]
November 20, 2024
TOPLINE: Combining transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS) was associated with a greater reduction in symptoms of major depressive disorder (MDD) […]
November 20, 2024
The well-being of doctors is under significant strain, with acute and chronic stress, psychological trauma, ethical dilemmas, and negative experiences contributing to burnout and depression. This […]
November 18, 2024
TOPLINE: Physical activity of any intensity after a diagnosis of dementia is associated with a significantly lower risk for all-cause mortality, a new study showed. Researchers […]
November 18, 2024
LISBON, Portugal — Europe needs a Child Health Exposome Mission to better understand how to prevent, diagnose, and treat diseases over the life course, protecting the […]